Boosting NAD+ Blunts Toll-Like Receptor-4 Induced Type-I Interferon in Control and Systemic Lupus Erythematosus Monocytes Clinical, Inflammation/Immune HealthANAD StaffJanuary 13, 2022
Combined Metabolic Activators Therapy Ameliorates Liver Fat in Nonalcoholic Fatty Liver Disease Patients Clinical, Liver HealthANAD StaffOctober 25, 2021
Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia Clinical, Ataxia Telangiectasia, Neurological HealthANAD StaffSeptember 13, 2021
Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19 Clinical, Inflammation/Immune HealthANAD StaffJune 28, 2021
NAD+-Boosting Therapy Alleviates Nonalcoholic Fatty Liver Disease via Stimulating a Novel Exerkine Fndc5/Irisin Clinical, Liver HealthANAD StaffFebruary 25, 2021
Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans Clinical, Metabolic HealthANAD StaffFebruary 1, 2021
Nicotinamide Riboside Supplementation Does Not Alter Whole-Body or Skeletal Muscle Metabolic Responses to a Single Bout of Endurance Exercise Clinical, Muscle HealthANAD StaffJanuary 25, 2021
Variable Selection in Untargeted Metabolomics and the Danger of Sparsity Clinical, Ataxia Telangiectasia, Neurological HealthANAD StaffNovember 17, 2020
Boosting NAD Level Suppresses Inflammatory Activation of PBMCs in Heart Failure Clinical, Cardiovascular HealthANAD StaffAugust 13, 2020
The Acute Effect of Metabolic Cofactor Supplementation: A Potential Therapeutic Strategy Against Non-Alcoholic Fatty Liver Disease Clinical, Liver HealthANAD StaffApril 27, 2020
Nicotinamide Riboside Supplementation Alters Body Composition and Skeletal Muscle Acetylcarnitine Concentrations in Healthy Obese Humans Clinical, Metabolic Health, Muscle HealthANAD StaffApril 22, 2020
Nicotinamide Riboside Does Not Alter Mitochondrial Respiration, Content or Morphology in Skeletal Muscle from Obese and Insulin-Resistant Men Clinical, Metabolic Health, Muscle HealthANAD StaffNovember 11, 2019
Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures Clinical, Muscle HealthANAD StaffAugust 13, 2019
Effects of Nicotinamide Riboside on Endocrine Pancreatic Function and Incretin Hormones in Nondiabetic Men With Obesity Clinical, Metabolic HealthANAD StaffAugust 7, 2019
Safety and Metabolism of Long-Term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Healthy Overweight Adults Clinical, Pharmacokinetic/SafetyANAD StaffJuly 5, 2019
A Randomized Placebo-Controlled Clinical Trial of Nicotinamide Riboside in Obese Men: Safety, Insulin-Sensitivity, and Lipid-Mobilizing Effects Clinical, Pharmacokinetic/Safety, Liver Health, Metabolic HealthANAD StaffJuly 10, 2018
Chronic Nicotinamide Riboside Supplementation is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults Clinical, Pharmacokinetic/SafetyANAD StaffMarch 29, 2018
An Open-Label, Non-Randomized Study of the Pharmacokinetics of the Nutritional Supplement Nicotinamide Riboside (NR) and Its Effects on Blood NAD+ Levels in Healthy Volunteers Clinical, Pharmacokinetic/SafetyANAD StaffDecember 6, 2017
Nicotinamide Riboside is Uniquely and Orally Bioavailable in Mice and Humans Clinical, Pharmacokinetic/SafetyANAD StaffOctober 10, 2016
